|
|
|
LifeScienceHistory.com - Check us out on Instagram
Georgia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing GeorgiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
GeoVax, Inc.
| | | Phone: | (678) 384-7220 | Fax: | (678) 384-7281 | Year Established: | 2001 | Ticker: | GOVX | Exchange: | OTCQB | Main Contact: | David A. Dodd, Chairman, President, CEO | | Other Contacts: | Harriet L. Robinson, Ph.D., CSO Emeritis Farshad Guirakhoo, Ph.D., CSO Mark W. Reynolds, CFO
| | Company Description | GeoVaxis a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using their novel Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform technology. Their platform supports production of non-infectious virus-like particles (VLPs) from the cells of the person receiving the vaccine. Producing VLPs in the person being vaccinated mimics a natural infection, stimulating both the humoral and cellular arms of the immune system to recognize, prevent and control the target infection should it appear. | |
|
|
|
|
|